This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MEYER J. BARRASH, M.D.; MILTON FORT, M.D.

Arch Intern Med. 1960;106(2):271-274.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The availability of the antifungal antibiotic amphotericin B necessitates its careful evaluation in the treatment of a heretofore uniformly fatal illness, torula meningitis. The recent past has seen other new and promising agents used, evaluated, and found to be wanting.¹ Because central nervous system infections due to Cryptococcus neoformans may have long periods of spontaneous remission, final judgment of any specific therapy will have to await the test of time. However, if promising results are now obtained through the use of amphotericin B, physicians should be made aware so that no clinical case of torulosis goes untreated while the final data are being accumulated.

We are reporting this case of torula meningitis as an instance of the life-saving ability of amphotericin B. If the course of a steadily worsening illness is sharply and definitely reversed promptly after the beginning of a specific therapy, it behooves one to, at least, . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

Footnotes
Submitted for publication Oct. 10, 1959.

Assistant Professor, Chicago Medical School, Department of Medicine; Adjunct Physician Michael Reese Hospital (Dr. Barrash). Formerly Resident in Medicine, Michael Reese Hospital, now U.S. Air Force (Dr. Fort).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?